Deadly, rare lung cancer finds big foe: Patients with little to lose

Posted by ALCF Staff on February 8th, 2017
No Comments

From The San Francisco Business Times:
“Between sessions of the World Lung Cancer Conference in Denver in September 2015, [Lisa] Goldman and another ROS1 patient, Janet Freeman-Daily, had a simple question for ROS1 expert Dr. Ross Camidge of the University of Colorado: What can patients do?”

Read more at the San Francisco Business Times to learn about the work ALCF is doing, at the request of our patients to study the ROS1 gene.

About Guneet Walia, PhD

Dr. Guneet Walia is here to serve as your guide through what can feel like an overwhelming amount of information and jargon in lung cancer research. With her extensive background in oncology & drug development in the lab and experience working with cancer patients, she culls through the latest news to bring you the most important developments that can impact you and your disease today. If you have any questions, please don't hesitate to get in touch with Dr. Walia.
Leave a Reply: